Influenza Virus

Influenza virus inhibitors act on viral RNA synthesis, nucleoprotein function, the M2 ion channel and host factors. Influenza A and B viruses carry a segmented, negative-sense RNA genome that is transcribed and replicated in the nucleus of infected cells. Favipiravir, a pyrazinecarboxamide, is converted in cells into a ribonucleotide form that inhibits the viral RNA-dependent RNA polymerase. Amantadine hydrochloride blocks the M2 proton channel of influenza A virus, a step required for release of the viral genome. Nucleozin binds the viral nucleoprotein and causes it to aggregate, which prevents its accumulation in the nucleus. Host-directed compounds include SC75741, an inhibitor of nuclear factor kappa B (NF-κB) signaling, and the heat shock protein 90 (Hsp90) inhibitor geldanamycin.

1 Item

  • RIG-1 modulator 1
    Cat. No.
    A19536

    RIG-1 modulator 1

    RIG-1 modulator 1 is an anti-viral compound which can be useful for the treatment of viral infections including influenza virus, HBV, HCV and HIV extracted from patent WO 2015172099 A1.

    1 mg
    $40.00
    2 mg
    $60.00
    All 7 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...